WTR Healthcare Happenings
Celková doba trvání:
13 h 04 min
Cannara Biotech (LOVFF): Gaining Share in the Canadian Cannabis Market
WTR Healthcare Happenings
23:22
Oncolytics Biotech (ONCY): A Differentiated Approach to Treating Gastrointestinal Cancers
WTR Healthcare Happenings
25:11
The Psychedelic Inflection Point: Big Pharma, FDA, and the Next Wave of Brain Medicines
WTR Healthcare Happenings
22:22
Pulsenmore (PLSM): Safe and Sound: Pulsenmore Brings Prenatal Ultrasound Home
WTR Healthcare Happenings
23:42
Biotech M&A Is Back: What's Driving the 2026 Deal Surge
WTR Healthcare Happenings
11:05
Jupiter Neurosciences (JUNS): Jotrol’s Bioavailability Breakthrough and the Key Parkinson’s Phase 2A Readout
WTR Healthcare Happenings
22:56
NurExone Biologic (NRX): The Inhibitor of the Inhibitor: How Nurexone's ExoPTEN Is Designed to Restart Nerve Regeneration
WTR Healthcare Happenings
12:09
PharmAla Biotech (MDMA): Two Transactions, One Strategy: Unlocking Pipeline Value Through Structured Partnerships
WTR Healthcare Happenings
18:01
Solvonis Therapeutics (SVNS): CSO Professor David Nutt on Solvonis' Approach to Resetting the Addicted Brain
WTR Healthcare Happenings
21:49
Solvonis Therapeutics (SVNS): Rewriting the Standard of Care for Severe Alcohol Use Disorder
WTR Healthcare Happenings
34:03
PetVivo Holdings (PETV): The Trifecta: Regenerative Science, AI-Enabled Vet Care, and Human Translation
WTR Healthcare Happenings
26:30
SBC Medical (SBC): Scaling Aesthetics, Longevity, and Global Growth
WTR Healthcare Happenings
20:30
ExoZymes (EXOZ): Unlocking Hard-to-Scale Molecules with AI-Driven, Cell-Free Biomanufacturing
WTR Healthcare Happenings
31:58
Hidden Gems - Unlocking Value in Biotech's Most Overlooked Stocks
WTR Healthcare Happenings
12:47
Vivos Therapeutics (VVOS): 2025 Results and Path to Cash Flow Breakeven by End-2026
WTR Healthcare Happenings
32:55
Trump's Psychedelic Medicine Executive Order: What It Means for Patients and Investors
WTR Healthcare Happenings
08:41
WTR Insights Conference Preview: Nurexone's Nerve Regeneration & Anixa's Cancer Immunotherapy in Focus
WTR Healthcare Happenings
05:47
Circular Genomics: Cracking the Brain Code with Circular RNA
WTR Healthcare Happenings
23:50
Unmasking the Treatment Landscape for Obstructive Sleep Apnea (OSA)
WTR Healthcare Happenings
11:55
Psychedelics at a Turning Point: The Trials That Could Change Mental Health Treatment
WTR Healthcare Happenings
13:28
Anixa Biosciences (ANIX): CEO Dr. Amit Kumar on Why 2026 Is Poised to Be a Defining Year
WTR Healthcare Happenings
24:26
Omniscient Neurotechnology: Scaling up Clinical Connectomics SaaS Strategy and Neurotech Vision
WTR Healthcare Happenings
30:17
Decoy Therapeutics (DCOY): CEO Rick Pierce on the Company’s Groundbreaking Approach to Drug Development in the AI/ML Era
WTR Healthcare Happenings
30:01
NurExone Biologic (OTCQB: NRXBF / TSXV: NRX): CEO Dr. Lior Shaltiel on How the Company Stands Out as an Early‑Clinical‑Stage Biotech
WTR Healthcare Happenings
11:38
Taking Aim at Norovirus; Cocrystal Pharma's (COCP) Clinical Antiviral Opportunity
WTR Healthcare Happenings
27:26
How Entropy Neurodynamics (ASX: ENP) Is Shaping Psychedelic‑Assisted Therapy: Psilocin Programs, Binge Eating Disorder, and EEG Biomarker
WTR Healthcare Happenings
28:12
Anixa' (ANIX) T-Cell Innovations Demonstrate Early Breakthrough Potential in Solid Tumors
WTR Healthcare Happenings
13:09
The lure of the NASDAQ for Biotechs
WTR Healthcare Happenings
07:11
Redefining Cancer Treatment: Calidi Biotherapeutics’ Approach to Enable Systemic Oncolytic Virotherapy for Metastatic Disease
WTR Healthcare Happenings
18:38
Co-Diagnostic' Technology to Deliver Accessible, High-Fidelity Gold Standard PCR Testing Like No Other
WTR Healthcare Happenings
19:47
CEO Jagi Gill on How Apyron' Innovative Neurostimulation Solution Breaks the Chronic Pain Barrier
WTR Healthcare Happenings
22:05
RenovoRx’ Differentiated Targeted Drug Delivery Platform Addressing Hypovascular cancers
WTR Healthcare Happenings
16:28
Vivos Therapeutics’ Mission to Transform Sleep Treatment
WTR Healthcare Happenings
11:03
GenSight Biologics' Novel Gene Therapy Approach to Reversing Blindness from Genetic Eye Disorders
WTR Healthcare Happenings
11:46
Ainos' Director of Corporate Development Jack Lu Discusses the AI Nose Platform' continuing 2025 momentum and Looks Ahead into 2026
WTR Healthcare Happenings
15:21
The Psychedelic Investment Environment: A New Era of Optimism
WTR Healthcare Happenings
10:00
Solvonis Therapeutics: Redefining Treatment for Alcohol Use Disorder Through Capital-Efficient Innovation
WTR Healthcare Happenings
22:37
Reversing the Irreversible: NurExone Biologic’s (NRXBF) Regenerative Exosome Therapy for Spinal Cord and Nerve Injuries
WTR Healthcare Happenings
16:56
PharmAla Biotech’s CEO Nick Kadysh On Psychedelics, the FDA, and PharmAla’s Strategic Approach Post-Lykos CRL
WTR Healthcare Happenings
20:37
CEO Dr. Amit Kumar Discusses Anixa Biosciences' Innovative Approach to Help T-Cells Address Solid Tumors
WTR Healthcare Happenings
24:18
